Form 4: Teradyne Executive Sells Shares Under 10b5-1 Plan

Teradyne Inc. reports an executive's sale of 16 shares of common stock on April 8, 2026, as part of a pre-established 10b5-1 trading plan.

Summary

• Regan Mills, President of Product Test at Teradyne, Inc., sold 16 shares of common stock on April 8, 2026.
• The sale was executed at a price of $342.17 per share.
• This transaction was made pursuant to a Rule 10b5-1(c) sales plan adopted on November 25, 2025.
• The sale is an administrative correction related to tax withholding obligations for vested restricted stock units on April 1, 2026.
• Following this transaction, Mills beneficially owns 11,399.3452 shares of Teradyne common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves a stock sale by an executive, the transaction is conducted under a pre-established 10b5-1 plan and is an administrative correction, indicating routine compliance rather than a negative signal about the company's prospects.

Positives

• The transaction was conducted under a pre-arranged 10b5-1 plan, indicating adherence to established trading policies and avoiding insider trading concerns.
• The sale is an administrative correction for tax withholding, suggesting it's a routine event rather than a reaction to negative company performance.

Negatives

• An executive is selling company stock, which could be perceived negatively by the market, although the context of a 10b5-1 plan mitigates this concern.

Risks

• The filing does not explicitly mention any new or emerging risks.
• The sale of shares by an executive, even under a 10b5-1 plan, could be interpreted by some investors as a lack of confidence, though this is a standard practice.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future company performance. It solely reports a past transaction.

Management Comments

• The transaction was made pursuant to a sales plan adopted by the Reporting Person on November 25, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
• This is following an administrative correction to the number of shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on April 1, 2026, as reported on a Form 4 filed on April 3, 2026.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by Teradyne executives is a common practice in the semiconductor testing industry to manage personal stock sales in a compliant manner, especially given the cyclical nature and market sensitivity of the sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale is under a 10b5-1 plan, which is a standard and compliant method for executives to diversify holdings, thus minimizing negative impact.
• Employees: The transaction relates to executive compensation and tax obligations, with no direct impact on other employees.
• Management: The filing confirms adherence to established trading policies and regulatory requirements for beneficial ownership reporting.

Next Steps

• No specific future actions or milestones are mentioned in this filing.

Key Dates

Keywords

Teradyne, TER, Form 4, SEC Filing, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, Executive Compensation, Restricted Stock Units